Endothelin-1 (ET-1)—potentiated insulin secretion: Involvement of protein kinase C and the ETA receptor subtype
- 29 February 2000
- journal article
- Published by Elsevier in Metabolism
- Vol. 49 (2), 264-269
- https://doi.org/10.1016/s0026-0495(00)91585-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Circulating Endothelin-1 in Non-Insulin-Dependent Diabetic Patients with RetinopathyHormone and Metabolic Research, 1997
- Expression and Signal Transduction Pathways of Endothelin Receptors in Neuroendocrine CellsFrontiers in Neuroendocrinology, 1996
- Glucose-Dependent Insulinotropic Polypeptide Stimulates Insulin Secretion via Increased Cyclic AMP and [Ca2+]iand a Wortmannin-Sensitive Signalling PathwayBiochemical and Biophysical Research Communications, 1996
- Endogenous Insulin Modulates Circulating Endothelin-1 Concentrations in HumansDiabetes Care, 1996
- An Inhibitory Role for Phosphatidylinositol 3-Kinase in Insulin Secretion from Pancreatic B Cell Line MIN6Biochemical and Biophysical Research Communications, 1995
- Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II‐restricted antigen presentationEuropean Journal of Immunology, 1994
- Neuroendocrine actions of endothelinsTrends in Pharmacological Sciences, 1992
- Endothelin-like immunoreactivity in rat models of diabetes mellitusJournal of Endocrinology, 1991
- Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase CBiochemical and Biophysical Research Communications, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988